

Cover Story
Free
By Matthew Bin Han Ong
FDA's passive reliance on self-reporting by hospitals and device manufacturers allowed harm caused by power morcellators to go unnoticed for over two decades—likely contributing to injury and deaths of hundreds of women, according to the U.S. Government Accountability Office said.
In Brief
Funding Opportunities
Drugs & Targets
Trending Stories
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- California Institute of Regenerative Medicine and Cancer Research: A promise broken?
- GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation
- Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable” - Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology
- Sustaining community oncology through nonprofit structures and shared technology infrastructure















